Skin Preparation for Prevention of Surgical Site Infection After Cesarean Delivery: A Randomized Controlled Trial

Obstet Gynecol. 2015 Dec;126(6):1251-1257. doi: 10.1097/AOG.0000000000001118.

Abstract

Objective: To compare chlorhexidine with alcohol, povidone-iodine with alcohol, and both applied sequentially to estimate their relative effectiveness in prevention of surgical site infections after cesarean delivery.

Methods: Women undergoing nonemergent cesarean birth at greater than 37 0/7 weeks of gestation were randomly allocated to one of three antiseptic skin preparations: povidone-iodine with alcohol, chlorhexidine with alcohol, or the sequential combination of both solutions. The primary outcome was surgical site infection reported within the first 30 days postpartum. Based on a surgical site infection rate of 12%, an anticipated 50% reduction for the combination group relative to either single skin preparation group, with a power of 0.90 and an α of 0.05, 430 women per group were needed to detect a difference.

Results: From January 2013 to July 2014, 1,404 women were randomly assigned to one of three groups: povidone-iodine with alcohol (n=463), chlorhexidine with alcohol (n=474), or both (n=467). The groups were similar with respect to demographics, medical disorders, indication for cesarean delivery, operative time, and blood loss. The overall rate of surgical site infection-4.3%-was lower than anticipated. The skin preparation groups had similar surgical site infection rates: povidone-iodine 4.6%, chlorhexidine with alcohol 4.5%, and sequential 3.9% (P=.85).

Conclusion: The skin preparation techniques resulted in similar rates of surgical site infections. Our study provides no support for any particular method of skin preparation before cesarean delivery.

Clinical trial registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01870583.

Level of evidence: I.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • 2-Propanol / therapeutic use*
  • Administration, Cutaneous
  • Adult
  • Anti-Infective Agents, Local / therapeutic use*
  • Cesarean Section*
  • Chlorhexidine / therapeutic use*
  • Drug Combinations
  • Drug Therapy, Combination
  • Female
  • Humans
  • Logistic Models
  • Povidone-Iodine / therapeutic use*
  • Pregnancy
  • Preoperative Care / methods*
  • Surgical Wound Infection / epidemiology
  • Surgical Wound Infection / prevention & control*
  • Treatment Outcome

Substances

  • Anti-Infective Agents, Local
  • Drug Combinations
  • Povidone-Iodine
  • 2-Propanol
  • Chlorhexidine

Associated data

  • ClinicalTrials.gov/NCT01870583